tiprankstipranks
Trending News
More News >
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market
Advertisement

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Financial Statements

Compare
5 Followers

GlaxoSmithKline Pharmaceuticals Limited Financial Overview

GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹463.45B. The company's EPS TTM is ₹12.1; its P/E ratio is 48.76; and it has a dividend yield of 1.97%. GlaxoSmithKline Pharmaceuticals Limited is scheduled to report earnings on August 1, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

GlaxoSmithKline Pharmaceuticals Limited Debt to Assets

GlaxoSmithKline Pharmaceuticals Limited Cash Flow

GlaxoSmithKline Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis